| Metric | FY 2025↕ | FY 2024↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $147.1B | $150.0B | $148.3B | $137.9B | $30.7B | $28.9B | $28.1B | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $3.8B | $3.1B | $4.1B | $3.5B | $-0.2B | $0.5B | $0.4B | $0.0B |
| Net Income | $2.7B | $2.2B | $2.2B | $1.7B | $-0.1B | $0.3B | $0.3B | $0.9B |
| EPS (Basic) | $3.70 | $2.99 | $3.10 | $2.20 | $-0.10 | $0.40 | $0.32 | $0.97 |
| EPS (Diluted) | $3.67 | $2.96 | $3.06 | $2.17 | $-0.10 | $0.40 | $0.32 | $0.96 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $52.6B | $50.5B | $49.6B | $49.1B | $48.7B | $45.3B | $38.1B | $37.2B |
| Current Assets | $15.3B | $12.9B | $12.7B | $12.2B | $12.5B | $10.9B | $10.8B | $11.1B |
| Cash & Equivalents | $4.0B | $1.9B | $1.0B | $1.8B | $1.7B | $0.4B | $0.4B | $0.3B |
| Total Liabilities | $44.3B | $38.9B | $39.6B | $39.7B | $39.1B | $36.7B | $30.3B | $30.3B |
| Current Liabilities | $15.9B | $16.1B | $17.2B | $16.3B | $15.4B | $14.2B | $14.3B | $14.2B |
| Stockholders' Equity | $8.3B | $11.6B | $10.0B | $9.5B | $9.6B | $8.6B | $7.9B | $6.9B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $5.8B | $6.8B | $4.5B | $6.2B | $6.8B | $4.7B | $4.2B | $3.4B |
| Investing Cash Flow | $-3.2B | $-3.8B | $-3.0B | $-2.6B | $-2.8B | $-2.6B | $-1.2B | $-2.7B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.5B | $-2.2B | $-2.3B | $-3.4B | $-2.7B | $-2.1B | $-2.9B | $-0.7B |